This Session will look at new technological advancements and innovations to accelerate the development and commercialization of vaccines to address the threat of future epidemics. Speakers from the Bill & Melinda Gates Foundation and Apiject will provide an overview of how each working to provide low cost, high reliability vaccine manufacturing.

Session Moderator

Mark A. Butler – President and Managing Director, IPS

Speaker

Philippe-Alexander Gilbert, Ph.D.

Senior Program Officer CMC

Bill & Melinda Gates Foundation